RVPH (Reviva Pharmaceuticals Holdings) FFO


RVPH Reviva Pharmaceuticals Holdings Inc RVPH
22 GF Score
Price $0.67
! 1 Warning Sign
View Full Analysis

What is Reviva Pharmaceuticals Holdings FFO?

FFO (Funds from operations) only applies to REITs.

RVPH
22GF Score
Reviva Pharmaceuticals Holdings Inc RVPH
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Reviva Pharmaceuticals Holdings Business Description

Address 10080 North Wolfe Road, Suite SW3-200, Cupertino, CA, USA, 95014
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063), which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis, and its other drug candidate is RP1208.
22GF Score

Get the complete analysis for RVPH

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.67
Price